Inceptionr LLC Purchases 15,225 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Inceptionr LLC lifted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 159.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 24,773 shares of the company’s stock after buying an additional 15,225 shares during the period. Inceptionr LLC’s holdings in Bath & Body Works were worth $960,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in BBWI. Golden State Wealth Management LLC bought a new position in shares of Bath & Body Works in the fourth quarter worth approximately $26,000. SRS Capital Advisors Inc. lifted its stake in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after buying an additional 329 shares in the last quarter. True Wealth Design LLC lifted its stake in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after buying an additional 1,054 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Bath & Body Works in the third quarter worth approximately $39,000. Institutional investors own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on BBWI shares. Raymond James reiterated an “outperform” rating and issued a $46.00 target price (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and increased their price objective for the company from $40.00 to $48.00 in a research report on Friday, February 28th. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Finally, Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $42.00 to $48.00 in a research report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $45.06.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $34.18 on Friday. The firm has a fifty day moving average price of $37.37 and a 200-day moving average price of $34.18. The stock has a market cap of $7.40 billion, a PE ratio of 8.34, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.34%. Bath & Body Works’s dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works declared that its board has authorized a stock buyback plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.